Sucampo Pharmaceuticals, Inc.
SCMP
SCMP was delisted on the 12th of February, 2018.
81 hedge funds and large institutions have $79.9M invested in Sucampo Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 15 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 15
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
9% more funds holding
Funds holding: 74 → 81 (+7)
10% less capital invested
Capital invested by funds: $88.8M → $79.9M (-$8.89M)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $1.06M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.51M |
| 2 |
Millennium Management
New York
|
+$2.81M |
| 3 |
VAM
Visium Asset Management
New York
|
+$2.24M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$1.91M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$8.7M |
| 2 |
AG
Algert Global
San Francisco,
California
|
-$939K |
| 3 |
D.E. Shaw & Co
New York
|
-$614K |
| 4 |
BA
Boston Advisors
Boston,
Massachusetts
|
-$469K |
| 5 |
Renaissance Technologies
New York
|
-$338K |
SCMP Hedge Fund Activity: Q1 2014 in Review
81 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2014, worth a combined $79.9M — down 10% from $88.8M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new SCMP positions and 9 closed out — a net gain of 7 holders — while 35 added to existing stakes and 15 trimmed.
The largest buyer was Putnam Investments, adding an estimated $4.51M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $8.7M sold.
- 81 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2014, up from 74 in Q4 2013.
- Funds reported $79.9M of Sucampo Pharmaceuticals, Inc. stock for Q1 2014, down 10% quarter-over-quarter.
- 16 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2014 and 9 closed out, a net change of +7 holders.
- The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2014 was Putnam Investments, an estimated $4.51M added.
- The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2014 was Consonance Capital Management, an estimated $8.7M sold.
Based on aggregated 13F filings for Q1 2014.